Bottom line
PHLAX vs QAAGZX: the short answer
PHLAX (PGIM Jennison Health Sciences Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 51% by weight.
But QAAGZX is far broader, holding 277 positions to 55 for PHLAX, so beyond the top names it adds exposure PHLAX doesn't have.
QAAGZX is cheaper at 0.86% vs 1.15% — a difference of $29 a year per $10,000 invested.
Over five years, PHLAX returned +5.5% a year vs +4.1% for QAAGZX (reporting dates differ).
PHLAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PHLAX vs QAAGZX side by side
| PHLAX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | PGIM (Prudential) | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.15% | 0.86% |
| Annual cost per $10k | $115 | $86 |
| 10-yr cost on $10k (prospectus) | $1,871 | $1,061 |
| Max front load | 5.5% | None |
| 12b-1 fee | 0.3% | 0% |
| 1-yr return | +12.7% | +18.1% |
| 5-yr return (annualized) | +5.5% | +4.1% |
| 10-yr return (annualized) | +8.9% | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $1.4B | $751.7M |
| Number of holdings | 55 | 277 |
| Portfolio turnover | 81% | 65% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of PHLAX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | PHLAX | QAAGZX |
|---|---|---|
| Eli Lilly & Company | 17.35% | 14.06% |
| Merck & Company Inc | 6.06% | 4.00% |
| Unitedhealth Group Inc | 5.87% | 5.88% |
| Thermo Fisher Scientific Inc | 4.56% | 2.53% |
| Vertex Pharmaceuticals Inc | 3.37% | 2.26% |
| Danaher Corp | 3.28% | 1.44% |
| Intuitive Surgical Inc | 3.07% | 1.89% |
| Cvs Health Corp | 2.52% | 0.93% |
| Stryker Corp | 2.16% | 1.78% |
Source: SEC Form N-PORT
PHLAX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between PHLAX and QAAGZX?
Which is cheaper, PHLAX or QAAGZX?
Should I own both PHLAX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.